20468 ⎘
Medicinal preparations containing organic active ingredients; Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
Estrogen receptor ligand and/or interferon beta treatment for neurodegenerative diseases
#902Androstenediol as an indicator for assessing estrogenicity
#903Uses of hypoxia-inducible factor inhibitors
#904EMERGENCY CONTRACEPTIVE
#905Device for transdermal administration of drugs including acrylic polymers
#906Indian Hedgehog (Ihh) as a Marker to Predict Osteoarthritis (OA) and Methods for the Prevention and Treatment of OA
#9072-Phenyl-1-[4-(2-Aminoethoxy)-Benzyl]-Indole and estrogen formulations
#908ANDROGEN PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING DEPRESSION
#909Composition comprising benzoic acid in combination with organic acid preservatives as active ingredients and the use thereof
#9106-substituted estradiol derivatives for use in remyelination of nerve axons
#911Reversely thermo-reversible hydrogel compositions
#912METHODS FOR TREATING NEURAL CELL SWELLING
#913Neuroprotection and myelin repair using Nestorone®
#914HORMONE REPLACEMENT THERAPY AND DEPRESSION
#915Spreading implement
#916DROSPIRENONE FOR HORMONE REPLACEMENT THERAPY
#917Seizure and Migraine Treatments using the Bone Homeostasis Drug Cinacalcet
#918FULVESTRANT IN A DOSAGE OF 500mg FOR THE TREATMENT OF ADVANCED BREAST CANCER
#919MANAGEMENT OF BREAKTHROUGH BLEEDING IN EXTENDED HORMONAL CONTRACEPTIVE REGIMENS
#920METHODS AND DEVICES FOR THE SUSTAINED RELEASE OF MULTIPLE DRUGS
#921FORMULATIONS AND METHODS FOR RECOVERY FROM DENTAL SURGERY
#922MEDICATION FOR ORAL ADMINISTRATION, COMPRISING AT LEAST ONE ESTROGEN AND/OR AT LEAST ONE GESTAGEN AND AT LEAST ONE PROBIOTIC BACTERIAL STRAIN
#923Chemical induction of lactation
#924Compositions and methods for increasing lifespan and health span
#925INSULIN-PRODUCING CELL INDUCER, GLUCOSE INTAKE ENHANCER, AND THERAPEUTIC AGENT FOR DIABETES OR DIABETES COMPLICATIONS
#926Time-release and micro-dose formulations for topical application of estrogen and estrogen analogs or other estrogen receptor modulators in the treatment of dry eye syndrome, and methods of preparation and application
#927METHOD FOR THE PRODUCTION OF COMMERCIAL NANOPARTICLE AND MICRO PARTICLE POWDERS
#928Treatment of menopause-associated symptoms
#929Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof
#930COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF HYPERTENSION
#931Methods useful in the treatment of bone resorption diseases
#932Multi-layered gradient vaginal ring
#933Pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitors
#934BUCCAL APPLICATION SYSTEM COMPRISING 17A-ESTRADIOL
#935PARTICLES FOR DRUG DELIVERY AND OTHER APPLICATIONS
#936Estrogen antagonists as treatments for sclerosing disorders
#937Contraception process and administration form for the same
#938MICROSPHERE DRUG CARRIER, PREPARATION METHOD, COMPOSITION AND USE THEREOF
#939PARTICLES COMPRISING DROSPIRENONE ENCAPSULATED IN A POLYMER
#940Tanaproget compositions containing ethinyl estradiol
#941METHODS AND COMPOSITIONS RELATED TO SYNERGISTIC RESPONSES TO ONCOGENIC MUTATIONS
#942Compositions for nail and skin treatment
#943METHODS FOR DETERMINING THE ONCOGENIC CONDITION OF CELL, USES THEREOF, AND METHODS FOR TREATING CANCER
#944Compositions and methods for the prevention and treatment of red blood cell coagulation
#945Methods And Compositions Related To Synergistic Responses To Oncogenic Mutations
#946Combined and extracts for the therapeutic treatment of heart failure
#947COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF CORONARY HEART DISEASES
#948Compositions and methods for the prevention and treatment of brain diseases and conditions
#949Steroid compounds and treatment methods
#950ANDROGEN PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING DEPRESSION
#951FORMULATION COMPRISING DROSPIRENONE FOR SUBCUTANEOUS OR INTRAMUSCULAR ADMINISTRATION
#952ANDROGEN PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING DEPRESSION
#953METHODS AND REAGENTS FOR THE TREATMENT OF IMMUNOINFLAMMATORY DISORDERS
#954Growth promotion of animals by simultaneous release of steroid compounds from a device
#955Estrus Synchronization Preparations & Effective CIDR-Less Protocols
#956COMMERCIAL SCALE PRODUCTION METHODS FOR TRANSDERMAL HORMONE FORMULATIONS
#957MOLECULAR ACTIVATORS OF THE WNT/BETA-CATENIN PATHWAY
#958Therapeutics And Methods For Treating Neoplastic Diseases Comprising Determining The Level Of Caveolin-1 And/Or Caveolin-2 In A Stromal Cell Sample
#959CYCLODEXTRIN NANOTECHNOLOGY FOR OPHTHALMIC DRUG DELIVERY
#960ORAL CONTRACEPTION WITH TRIMEGESTONE
#961Estriol Therapy for Autoimmune and Neurodegenerative Disease and Disorders
#962Composition for the treatment of oxidative stress
#963Methods and apparatus for transdermal or transmucosal application of testosterone
#964Combination Hormone Therapy for the Eye
#965Fulvestrant nanosphere/microsphere and preparative method and use thereof
#966Combination of a Silicon Containing Component and a Hormone
#967ANDROGEN PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING DEPRESSION
#968PROGESTIN-CONTAINING DRUG DELIVERY SYSTEM
#969Pyrazolo[3,4-d]pyrimidine-4,6(5H,7H)-dione derivatives useful as inhibitors of phosphodiesterase 1
#970Very low-dosed solid oral dosage forms for HRT
#971Delivery of estrogen and bioequivalents thereof via the pulmonary tract
#972Contraceptive transdermal delivery of hormones
#973Contraceptive transdermal delivery of hormones
#974Estrogen receptor ligand and/or interferon beta treatment for neurodegenerative diseases
#975Contraceptive transdermal delivery of hormones
#976ESTRIOL FORMULATIONS
#977INTRAVAGINAL DELIVERY SYSTEM AND PROCESS FOR MANUFACTURING IT
#978PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING HYPOGONADISM
#979The Use of Oestrogen Applied to the Penis to Reduce HIV Infections
#980Method, device, and kit for maintaining physiological levels of steroid hormone in a subject
#981Use of Fulvestrant in the Treatment of Resistant Breast Cancer
#982Biomarkers for painful intervertebral discs and methods of use thereof
#9839-ALPHA ESTRATRIENE DERIVATIVES AS ER-BETA SELECTIVE LIGANDS FOR THE PREVENTION AND TREATMENT OF INTESTINAL CANCER
#984Dosace Form For Hormonal Contraceptive
#985PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING HYPOGONADISM
#986Method of treating human skin and a skin care composition for use in such a method
#987SULFONYLUREA RECEPTOR AND MEANS FOR TREATING ISCHAEMIA
#988METHOD OF PRODUCING A COMPOSITION FROM AN OLEOGEL AND AN AQUEOUS GEL AND THE COMPOSITION
#989Transdermal systems containing multilayer adhesive matrices to modify drug delivery
#990INTRAUTERINE DELIVERY SYSTEM FOR CONTRACEPTION
#991SUGAR COATINGS AND METHODS THEREFOR
#992Pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitors
#993Methods And Compositions For The Treatment of Autoimmune Disorders
#994ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
#995ENCAPSULATED OR COATED STENT SYSTEMS
#996Implantable delivery device
#997Steroid compounds and formulations
#998Transdermal pharmaceutical compositions comprising active agents
#999COMBINATION OF A PARP INHIBITOR AND AN AKT KINASE ACTIVATING COMPOUND
#1000ESTRADIOL-CONTAINING DRUG DELIVERY SYSTEM
#1001Methods for treating spinal cord injury with a compound that inhibits a NCCA-ATP channel
#1002Therapeutic vaginal emollient
#1003Coating system and method for drug elution management
#1004In-situ gel ophthalmic drug delivery system of estradiol or other estrogen for prevention of cataracts
#1005Method for treating inflammatory conditions
#1006Methods for inhibiting the development of huntington's disease
#1007ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
#1008System for use by compounding pharmacists cists to produce hormone replacement medicine customized for each customer
#1009Methods useful in the treatment of bone resorption diseases
#1010ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
#1011Graduated estrogen contraceptive
#1012DRUG DELIVERY SYSTEM WITH STABILISING EFFECT
#1013STEROID HORMONE PRODUCTS AND METHODS FOR PREPARING THEM
#1014STEROID HORMONE PRODUCTS AND METHODS FOR PREPARING THEM
#1015Combination product comprising SRC kinase inhibitor AZDO530 and an antioestrogen or EGFR-TK-inhibitor
#1016PHARMACEUTICAL COMPOSITION IN THE FORM OF A HYDROGEL FOR TRANSDERMAL ADMINISTRATION OF ACTIVE INGREDIENTS
#1017Polymeric compositions comprising therapeutic agents in crystalline phases, and methods of forming the same
#1018Methods and compositions for treating trauma-hemorrhage using estrogen and derivatives thereof
#1019Modified, hydroxy-substituted aromatic structures having cytoprotective activity
#1020Pharmaceutical containing a hormone combination having a contraceptive effect and an insulin sensitizer
#1021Method for measuring aromatase activity
#1022Topical compositions for anti-aging and methods of using same
#1023FILM COATED TABLETS CONTAINING DROSPIRENONE AS ACTIVE AGENT AND A METHOD FOR THE PREPARATION THEREOF
#1024NANOPARTICULATE COMPOSITIONS OF ANGIOGENESIS INHIBITORS
#1025Hormone delivery system and method
#1026Method of treating female sexual dysfunction with a PDE1 inhibitor
#1027NANOPARTICULATE COMPOSITIONS OF ANGIOGENESIS INHIBITORS
#1028NANOPARTICULATE COMPOSITIONS OF ANGIOGENESIS INHIBITORS
#1029Medicament Based On a Monoester of Steroids With Long Chain Fatty Acids
#1030COMPOSITIONS AND METHODS FOR CONTROLLING DRUG LOSS AND DELIVERY IN TRANSDERMAL DRUG DELIVERY SYSTEMS
#1031METHOD FOR THE TREATMENT OR PREVENTION OF LOWER URINARY TRACT SYMPTOMS
#1032Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
#1033TRANSDERMAL DELIVERY SYSTEM
#1034ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
#1035ANTAGONIST AGAINST TOLERANCE TO ANTICANCER DRUGS
#1036INDAZOLE INHIBITORS OF TYROSINE KINASE
#1037VAGINAL DELIVERY SYSTEM
#1038ORAL CONTRACEPTION WITH TRIMEGESTONE
#1039TRANSDERMAL DELIVERY SYSTEM FOR HORMONES AND STEROIDS
#1040Topical compositions for anti-aging and methods of using same
#1041Topical compositions for anti-aging and methods of using same
#1042OCULAR THERAPEUTIC AGENT DELIVERY DEVICES AND METHDOS FOR MAKING AND USING SUCH DEVICES
#1043METHOD OF MANUFACTURE OF COMPRESSED PHARMACEUTICAL FORMULATION CONTAINING TIBOLONE
#1044METHOD OF REDUCING THE EFFECTS OF CYTOSTATIC DRUGS ON BONE MARROW DERIVED CELLS, AND METHODS OF SCREENING
#1045Anti-angiogenic nanoparticle compositions
#1046Cancer treatment methods
#1047ARTICLES AND METHODS OF TREATING VASCULAR CONDITIONS
#1048Pharmaceutical compositions-4
#1049Liquid Bevirimat Dosage Forms for Oral Administration
#1050Transdermally absorbable preparation
#1051Treatment of Oestrogen Dependant Conditions in Pre-menopausal Women
#1052Bone microenvironment modulated seizure treatments
#1053Pregnancy hormone combination for treatment of autoimmune diseases
#1054Suppression of glial fibrillary acidic protein
#1055Treatment of meconium aspiration syndrome with estrogens
#1056Treatment or prevention of hypertensive disorders of pregnancy or fetal growth retardation
#1057ULTRASONIC NANOTHERAPY OF SOLID TUMORS WITH BLOCK COPOLYMERS STABILIZED PERFLUOROCARBON NANODROPLETS
#1058EXTENDED ESTROGEN DOSING CONTRACEPTIVE REGIMEN
#1059KLOTHO BETA
#1060Formulation
#1061Transdermal therapeutic system comprising norelestromin for contraception and hormone replacement
#1062PHARMACEUTICAL COMPOSITIONS CONTAINING TESTOSTERONE AND AN AROMATASE INHIBITOR
#1063COMPOSITION COMPRISING A GLYCOLYTIC INHIBITOR AND A RING SYSTEM COMPRISING A SULPHAMATE GROUP FOR THE TREATMENT OF CANCER
#1064Targeting NCchannel for organ protection following ischemic episode
#1065METHODS OF ENHANCING LYSOSOMAL STORAGE DISEASE THERAPY BY MODULATION OF CELL SURFACE RECEPTOR DENSITY
#1066PODOPHYLLOTOXIN INHIBITORS OF TOPOISOMERASE II
#1067COMPOSITIONS FOR AEROSOLIZATION OF HIGHLY CONDUCTIVE SOLUTIONS
#1068MEDICAMENTS
#1069Cyclic peptide compositions for treatment of sexual dysfunction
#1070Dosages for menstrual suppression, contraception, and hormone replacement therapy, and methods of administering same
#1071Monounsaturated fatty acids and perhydrocyclopentanophenanthrene nucleus combination molecules, and their precursors, and the use of all of these as weight-loss agents
#1072ANTI-ANGIOGENIC ACTIVITY OF 2-METHOXYESTRADIOL ANALOGS IN COMBINATION WITH ANTI-CANCER AGENTS
#1073Method of treating or preventing infertility in a female mammal and pharmaceutical kit for use in such method
#1074Pharmaceutical Compositions Comprising Flibanserin and a Further Agent in the Treatment of Sexual Disorders
#1075DROSPIRENONE FOR HORMONE REPLACEMENT THERAPY
#1076Compositions and methods for treatment of viral diseases
#1077METHOD OF TREATING AND PREVENTING HYPERPARATHYROIDISM WITH ACTIVE VITAMIN D ANALOGS
#1078Methods and compositions for the treatment of estrogen-dependent hyperproliferative uterine disorders
#1079MODULATION OF NITRIC OXIDE SIGNALING TO NORMALIZE TUMOR VASCULATURE
#1080ORAL MODIFIED RELEASE FORMULATIONS
#1081IDO inhibitors and methods of use thereof
#1082Low Dose Estrogen Interrupted Hormone Replacement Therapy
#1083Drug comprising at least one gestagen
#1084METHODS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF BONE LOSS
#1085Intravaginal Devices With a Rigid Support, Methods of Making, and Uses Thereof
#1086Steroidal compounds as melanogenesis modifiers and uses thereof
#1087Method of embryo transfer that eliminates transferred air while hormonally inducing implantation and apparatus
#1088STEP-DOWN ESTROGEN REGIMEN FOR WOMEN RECEIVING ESTROGEN THERAPY
#1089COMBINATION OF A LANTHANUM COMPOUND AND BONE ENHANCING AGENT FOR THE TREATMENT OF BONE DISEASES
#1090Transdermal estrogen device and delivery
#1091COMBINATION DRUG
#1092DUAL ADHESIVE TECHNOLOGY
#1093Transdermal hormone delivery system: compositions and methods
#1094Use of estriol in low doses
#1095ANDROGEN PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING DEPRESSION
#1096ACTIVE INGREDIENT COMBINATION OF A RETINOID AND A HORMONE COMBINATION WITH CONTRACEPTIVE ACTION AS MEDICAMENT FOR TREATMENT OF SKIN DISEASES
#1097Second line treatment of metastatic hormone refractory prostate cancer using satraplatin
#1098Transdermal hormone delivery system: compositions and methods
#1099Methods of inhibiting osteoclast activity
#1100Methods for identifying agents and their use for the prevention of restenosis
#1101METHOD OF MODULATION OF MULLERIAN INHIBITORY SUBSTANCE (MIS) RECEPTOR FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
#1102Estriol Therapy for Autoimmune and Neurodegenerative Disease and Disorders
#1103Extended cycle multiphasic oral contraceptive kit
#1104COMBINATION OF DEHYDROEPIANDROSTERONE OR DEHYDROEPIANDROSTERONE-SULFATE WITH AN ANTICHOLINERGIC BRONCHODILATOR FOR TREATMENT OF ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE
#1105PHARMACEUTICAL POLISH FORMULATIONS
#1106COMBINATION OF DEHYDROEPIANDROSTERONE OR DEHYDROEPIANDROSTERONE-SULFATE WITH A PDE-4 INHIBITOR FOR TREATMENT OF ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE
#1107Methods and devices for the sustained release of multiple drugs
#1108ORAL CONTRACEPTIVE DOSAGE FORMS AND METHODS OF MAKING SUCH DOSAGE FORMS
#1109TRANSDERMAL DRUG ADMINISTRATION DEVICE
#1110Regimens for Treatment of Conditions Related to Estrogen Deficiency
#1111Transdermal systems having control delivery system
#1112FULVESTRANT FORMULATIONS
#1113Fulvestrant formulations
#1114PHARMACEUTICAL COMPOSITION OF DROSPIRENONE AND ETHYNYLESTRADIOL
#1115HYDROXIDE-RELEASING AGENTS AS SKIN PERMEATION ENHANCERS
#11162-substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumor action
#1117Method of Treating An Acute Vascular Disorder
#1118Spray Composition for Topical Use for Treating and/or Preventing Herpes Simplex Labial Infections
#1119Pharmaceutical Compositions - 2
#1120Treatment of Prevention of Unscheduled Bleeding in Women on Progestogen Containing Medication
#1121Therapeutic Agent for Neuropathic Pain
#1122Resin composition, and temporary fixing method and surface protecting method for members to be processed, by means thereof
#1123Compositions and methods for treating Parkinson's disease and related disorders
#1124Methods of Step-Down Hormone Treatment
#1125Gabapentin-containing solid compositions and process for preparing the same
#1126Methods and pharmaceutical compositions for reliable achievement of acceptable serum testosterone levels
#1127Prevention or Treatment of Cancer Using Integrin alphavbeta3 Antagonists in Combination with Other Agents
#1128Anxiolytic marcgraviaceae compositions containing betulinic acid, betulinic acid derivatives, and methods
#1129VAGINAL DELIVERY SYSTEM
#1130NOVEL NON-SELECTIVE CATION CHANNEL IN NEURONAL CELLS AND METHOD FOR TREATING BRAIN SWELLING
#1131METHOD FOR TREATING AND PREVENTING HYPERPARATHYROIDISM
#1132Estriol Therapy for Autoimmune and Neurodegenerative Diseases and Disorders
#1133Therapeutic methods that target the NCchannel
#1134REGENERATION OF VAGINAL TISSUE WITH NON-SYSTEMIC VAGINAL ADMINISTRATION OF ESTROGEN
#1135Methods useful in the treatment of bone resorption diseases
#1136Use of Cymipristone Type Compounds in Aids Treatment
#1137BIOADHESIVE FILM
#1138Cell lines and animal models of HER2 expressing tumors
#1139METHOD FOR ALLEVIATING KERATOCONJUNCTIVITIS SICCA
#1140Prhormone composition and method of use thereof
#1141Pharmaceutical formulation for contraception and hormone-replacement therapy
#1142Drug delivery system
#1143FRAGRANCE COMPOSITIONS AND OTHER COMPOSITIONS WHICH CONTAIN NATURALLY OCCURRING SUBSTANCES FOUND IN CORALS
#1144Methods and Reagents for the Treatment of Inflammatory Disorders
#1145ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
#1146Modulation of Neurodegenerative Diseases Through The Progesterone Receptor
#1147METHODS AND DEVICES FOR THE SUSTAINED RELEASE OF MULTIPLE DRUGS
#1148Use of heat-shock protein 27 for cardiovascular disease prevention and treatment
#1149Anti Mineralocorticoid Therapy of Infection
#1150COMPOSITIONS AND KITS FOR COMPOUNDING PHARMACEUTICALS
#1151Suppression and prevention of tumors
#1152ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
#1153Pharmaceutical Compounds
#1154Identification and treatment of estrogen responsive prostate tumors
#1155PHARMACEUTICAL COMPOSITION FOR CONTRACEPTION AND BLOOD PRESSURE REGULATION, KIT FOR CONTRACEPTION CONTAINING SAME AND METHOD OF PRODUCTION OF SAME
#1156Contraceptive
#1157NEW DROSPIRENONE/17BETA-ESTRADIOL REGIMEN, PHARMACEUTICAL COMBINATION PRODUCT AND KIT FOR PERFORMING THIS REGIMEN
#1158NOVEL COMPOSITION TO INCREASE MUSCLE STRENGTH
#1159βGBP, compositions comprising βGBP, and related methods and uses thereof
#1160EXTERNAL PREPARATION
#1161Hormone replacement therapy
#1162Medicament Comprising A Hormone Combination
#1163Treatments of therapy resistant diseases and drug combinations for treating the same
#1164PHARMACEUTICAL PRODUCTS CONTAINING HORMONES AND A 25-HYDROXY VITAMIN D COMPOUND
#1165PHARMACEUTICAL PRODUCTS CONTAINING HORMONES AND A 25-HYDROXY VITAMIN D COMPOUND
#1166Method of Preventive On-Demand Hormonal Contraception
#1167Transdermal Systems Containing Multilayer Adhesive Matrices to Modify Drug Delivery
#1168METHODS AND DEVICES FOR THE SUSTAINED RELEASE OF MULTIPLE DRUGS
#1169Methods and devices for the sustained release of multiple drugs
#1170Method of Female Contraception and a Kit For Use Therein
#1171NANOPARTICULATE COMPOSITIONS OF ANGIOGENESIS INHIBITORS
#1172Enhancement of activity and/or duration of action of selected anti-inflammatory steroids for topical or other local application
#1173Steroid-Derived Pharmaceutical Compositions
#1174Method of Extending the Dose Range of Vitamin D Compounds
#1175Antagonist Against Tolerance to Anticancer Drugs
#1176Methods and devices for the sustained release of multiple drugs
#1177Oral contraceptive regimen
#1178Indibulin therapy
#1179Extended Use Combination Comprising Estrogens And Progestins
#1180PHARMACEUTICAL PRODUCT CONTAINING PROGESTIN, GENISTEIN, AND VITAMIN D COMPOUND
#1181Fibre-free transdermal therapeutic system and method for its production
#1182Method of treating immune pathologies with low dose estrogen
#1183NANOPARTICULATE COMPOSITIONS OF ANGIOGENESIS INHIBITORS
#1184Nanoparticulate compositions of angiogenesis inhibitors
#1185Method of treating immune pathologies with low dose estrogen
#1186Regimens for Controlled Drug Delivery Devices for Contraception
#1187ESTROGEN RECEPTOR MODULATORS ASSOCIATED PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE
#1188Low Dose Estrogen Interrupted Hormone Replacement Therapy
#1189Pharmaceutical compositions 3
#1190Breast and prostate cancer treatment method
#1191UPREGULATING ACTIVITY OR EXPRESSION OF BDNF TO MITIGATE COGNITIVE IMPAIRMENT IN ASYMPTOMATIC HUNTINGTON'S SUBJECTS
#1192TABLET-IN-TABLET COMPOSITIONS
#1193ESTROGEN/SERM AND ESTROGEN/PROGESTIN BI-LAYER TABLETS
#1194PREVENTION OF OVARIAN CANCER BY ADMINISTRATION OF A VITAMIN D COMPOUND
#1195Administration of estradiol metabolites for the treatment or prevention of obesity, metabolic syndrome, diabetes and vascular and renal disorders
#1196Spreading implement
#1197Enhanced drug delivery in transdermal systems
#1198Enhanced drug delivery in transdermal systems
#1199COMPOSITION CONTAINING PROGESTIN, PHYTOESTROGEN AND ESTROGEN
#1200PHARMACEUTICAL PRODUCT CONTAINING PROGESTIN, GENISTEIN, AND VITAMIN D COMPOUND